Safety of rhPDGF-BB for Medical and Cosmetic Applications
Published on January 27, 2026
Journal of Cosmetic Dermatology; 2026 Jan;25(1):e70636. doi: 10.1111/jocd.70636. First published: 30 December 2025
Lynch Regenerative Medicine is committed to advancing scientific understanding through transparent publication of safety and biological research. The following peer-reviewed manuscript reviews published safety data on recombinant human platelet-derived growth factor-BB (rhPDGF-BB).
DISCLAIMER: The accompanying article discusses approved and unapproved uses of recombinant human Platelet-Derived Growth Factor-BB (rhPDGF-BB or PDGF). Unapproved uses of PDGF have not been approved by the FDA, and the safety and effectiveness of PDGF for such unapproved uses have not been established. The article is provided for informational and scientific discussion purposes only and does not constitute promotion of any unapproved product or use.
